Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance

ACS Applied Materials and Interfaces

Volumn 7, Issue 32, 2015, Pages 18064-18075

  Hao, Tangna ^a   Chen, Dawei ^b,c   Liu, Kexin ^a   Qi, Yan ^a   Tian, Yan ^a   Sun, Pengyuan ^a   Liu, Yuanhong ^a   Li, Zhen ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

chemotherapy; doxorubicin; drug delivery; multidrug resistance; self assembled micelles; TPGS 2K

Indexed keywords

CELL CULTURE; CELL MEMBRANES; CHEMOTHERAPY; DRUG DELIVERY; DRUG PRODUCTS; ENCAPSULATION; MAMMALS; MEDICAL NANOTECHNOLOGY; MITOCHONDRIA; POLYETHYLENE GLYCOLS; POLYETHYLENES; TUMORS;

ANTI-TUMOR ACTIVITIES; BREAST CANCER TREATMENT; DOXORUBICIN; ENCAPSULATION EFFICIENCY; HISTOLOGICAL EXAMINATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIDRUG RESISTANCE; SELF-ASSEMBLED;

MICELLES;

ALPHA TOCOPHEROL; ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; MACROGOL DERIVATIVE; MICELLE; MULTIDRUG RESISTANCE PROTEIN;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG RELEASE; DRUG RESISTANCE; FEMALE; HUMAN; MCF 7 CELL LINE; METABOLISM; MICELLE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NUDE MOUSE; PATHOLOGY; PH; TEMPERATURE; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; DRUG LIBERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; P-GLYCOPROTEIN; POLYETHYLENE GLYCOLS; TEMPERATURE; TISSUE DISTRIBUTION; VITAMIN E;

EID: 84939839815     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.5b04995     Document Type: Article

References (51)

1. Baguley, B. C. Multidrug Resistance in Cancer Methods Mol. Biol. 2010, 596, 1-14 10.1007/978-1-60761-416-6-1
2. Gao, J.; Feng, S. S.; Guo, Y. Nanomedicine against Multidrug Resistance in Cancer Treatment Nanomedicine (London, U. K.) 2012, 7, 465-468 10.2217/nnm.12.11
3. Kathawala, R. J.; Gupta, P.; Ashby, C. R., Jr.; Chen, Z. S. The Modulation of ABC Transporter-mediated Multidrug Resistance in Cancer: a Review of the Past Decade Drug Resist. Updates 2015, 18, 1-17 10.1016/j.drup.2014.11.002
4. Binkhathlan, Z.; Lavasanifar, A. P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives Curr. Cancer Drug Targets 2013, 13, 326-346 10.2174/15680096113139990076
5. Liu, Y.; Fang, J.; Joo, K. I.; Wong, M. K.; Wang, P. Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor PLoS One 2014, 9, e110611 10.1371/journal.pone.0110611
6. Shaffer, B. C.; Gillet, J. P.; Patel, C.; Baer, M. R.; Bates, S. E.; Gottesman, M. M. Drug Resistance: Still a Daunting Challenge to the Successful Treatment of AML Drug Resist. Updates 2012, 15, 62-69 10.1016/j.drup.2012.02.001
7. Callaghan, R.; Luk, F.; Bebawy, M. Inhibition of the Multidrug Resistance P-glycoprotein: Time for a Change of Strategy? Drug Metab. Dispos. 2014, 42, 623-631 10.1124/dmd.113.056176
8. Torchilin, V. P. Structure and Design of Polymeric Surfactant-based Drug Delivery Systems J. Controlled Release 2001, 73, 137-172 10.1016/S0168-3659(01)00299-1
9. Maeda, H.; Bharate, G. Y.; Daruwalla, J. Polymeric Drugs for Efficient Tumor-targeted Drug Delivery Based on EPR-effect Eur. J. Pharm. Biopharm. 2009, 71, 409-419 10.1016/j.ejpb.2008.11.010
10. Xiao, H.; Song, H.; Yang, Q.; Cai, H.; Qi, R.; Yan, L.; Liu, S.; Zheng, Y.; Huang, Y.; Liu, T.; Jing, X. A Prodrug Strategy to Deliver Cisplatin(IV) and Paclitaxel in Nanomicelles to Improve Efficacy and Tolerance Biomaterials 2012, 33, 6507-6519 10.1016/j.biomaterials.2012.05.049
11. Liu, Y.; Rohrs, J.; Wang, P. Advances and Challenges in the Use of Nanoparticles to Optimize PK/PD Interactions of Combined Anti-cancer Therapies Curr. Drug Metab. 2014, 15, 818-828 10.2174/1389200216666150223152958
12. Sakai-Kato, K.; Nishiyama, N.; Kozaki, M.; Nakanishi, T.; Matsuda, Y.; Hirano, M.; Hanada, H.; Hisada, S.; Onodera, H.; Harashima, H.; Matsumura, Y.; Kataoka, K.; Goda, Y.; Okuda, H.; Kawanishi, T. General Considerations Regarding the in Vitro and in Vivo Properties of Block Copolymer Micelle Products and Their Evaluation J. Controlled Release 2015, 210, 76-83 10.1016/j.jconrel.2015.05.259
13. Chavanpatil, M. D.; Patil, Y.; Panyam, J. Susceptibility of Nanoparticle- Encapsulated Paclitaxel to P-glycoprotein-mediated Drug Efflux Int. J. Pharm. 2006, 320, 150-156 10.1016/j.ijpharm.2006.03.045
14. Kirtane, A. R.; Kalscheuer, S. M.; Panyam, J. Exploiting Nanotechnology to Overcome Tumor Drug Resistance: Challenges and Opportunities Adv. Drug Delivery Rev. 2013, 65, 1731-1747 10.1016/j.addr.2013.09.001
15. Batrakova, E. V.; Kabanov, A. V. Pluronic Block Copolymers: Evolution of Drug Delivery Concept from Inert Nanocarriers to Biological Response Modifiers. J. Controlled Release 2008, 130, 98-106. 10.1016/j.jconrel.2008.04.013
16. Collnot, E. M.; Baldes, C.; Schaefer, U. F.; Edgar, K. J.; Wempe, M. F.; Lehr, C. M. Vitamin E TPGS P-glycoprotein Inhibition Mechanism: Influence on Conformational Flexibility, Intracellular ATP Levels, and Role of Time and Site of Access Mol. Pharmaceutics 2010, 7, 642-651 10.1021/mp900191s
17. Hong, W.; Chen, D.; Zhang, X.; Zeng, J.; Hu, H.; Zhao, X.; Qiao, M. Reversing Multidrug Resistance by Intracellular Delivery of Pluronic® P85 Unimers Biomaterials 2013, 34, 9602-9614 10.1016/j.biomaterials.2013.08.032
18. Han, N.; Zhao, Q.; Wan, L.; Wang, Y.; Gao, Y.; Wang, P.; Wang, Z.; Zhang, J.; Jiang, T.; Wang, S. Hybrid Lipid-capped Mesoporous Silica for Stimuli-responsive Drug Release and Overcoming Multidrug Resistance ACS Appl. Mater. Interfaces 2015, 7, 3342-3351 10.1021/am5082793
19. Zhang, Z.; Tan, S.; Feng, S. S. Vitamin E TPGS as a Molecular Biomaterial for Drug Delivery Biomaterials 2012, 33, 4889-4906 10.1016/j.biomaterials.2012.03.046
20. Zhang, Z.; Feng, S. S. The Drug Encapsulation Efficiency, in Vitro Drug Release, Cellular Uptake and Cytotoxicity of Paclitaxel-loaded Poly(lactide)-tocopheryl Polyethylene Glycol Succinate Nanoparticles Biomaterials 2006, 27, 4025-4033 10.1016/j.biomaterials.2006.03.006
21. Kulkarni, S. A.; Feng, S. S. Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery Pharm. Res. 2013, 30, 2512-2522 10.1007/s11095-012-0958-3
22. Zhang, Z.; Lee, S. H.; Gan, C. W.; Feng, S. S. In Vitro and in Vivo Investigation on PLA-TPGS Nanoparticles for Controlled and Sustained Small Molecule Chemotherapy Pharm. Res. 2008, 25, 1925-1935 10.1007/s11095-008-9611-6
23. Feng, S. S.; Mei, L.; Anitha, P.; Gan, C. W.; Zhou, W. Poly(lactide)-vitamin E Derivative/Montmorillonite Nanoparticle Formulations for the Oral Delivery of Docetaxel Biomaterials 2009, 30, 3297-3306 10.1016/j.biomaterials.2009.02.045
24. Shieh, M. J.; Hsu, C. Y.; Huang, L. Y.; Chen, H. Y.; Huang, F. H.; Lai, P. S. Reversal of Doxorubicin-resistance by Multifunctional Nanoparticles in MCF-7/ADR cells J. Controlled Release 2011, 152, 418-425 10.1016/j.jconrel.2011.03.017
25. Li, Z.; Qiu, L.; Chen, Q.; Hao, T.; Qiao, M.; Zhao, H.; Zhang, J.; Hu, H.; Zhao, X.; Chen, D.; Mei, L. pH-sensitive Nanoparticles of Poly(L-histidine)-poly(lactide-co- glycolide)-tocopheryl Polyethylene Glycol Succinate for Anti-tumor Drug Delivery Acta Biomater. 2015, 11, 137-150 10.1016/j.actbio.2014.09.014
26. Muthu, M. S.; Kulkarni, S. A.; Liu, Y.; Feng, S. S. Development of Docetaxel-loaded Vitamin E TPGS Micelles: Formulation Optimization, Effects on Brain Cancer Cells and Biodistribution in Rats Nanomedicine (London, U. K.) 2012, 7, 353-364 10.2217/nnm.11.111
27. Yu, L.; Bridgers, A.; Polli, J.; Vickers, A.; Long, S.; Roy, A.; Winnike, R.; Coffin, M. Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing its Solubility and Permeability Pharm. Res. 1999, 16, 1812-1817 10.1023/A:1018939006780
28. Mi, Y.; Liu, Y.; Feng, S. S. Formulation of Docetaxel by Folic Acid-conjugated d-α-tocopheryl Polyethylene Glycol Succinate 2000 (Vitamin E TPGS(2k)) Micelles for Targeted and Synergistic Chemotherapy Biomaterials 2011, 32, 4058-4066 10.1016/j.biomaterials.2011.02.022
29. Hu, X.; Li, H.; Luo, S.; Liu, T.; Jiang, Y.; Liu, S. Thiol and pH Dual-responsive Dynamic Covalent Shell Cross-linked Micelles for Triggered Release of Chemotherapeutic Drugs Polym. Chem. 2013, 4, 695-706 10.1039/C2PY20701J
30. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M.; Nishiyama, N.; Kataoka, K. Accumulation of Sub-100 nm Polymeric Micelles in Poorly Permeable Tumours Depends on Size Nat. Nanotechnol. 2011, 6, 815-823 10.1038/nnano.2011.166
31. Cabral, H.; Kataoka, K. Progress of Drug-loaded Polymeric Micelles into Clinical Studies J. Controlled Release 2014, 190, 465-476 10.1016/j.jconrel.2014.06.042
32. Chen, Y.; Wu, Q.; Song, L.; He, T.; Li, Y.; Li, L.; Su, W.; Liu, L.; Qian, Z.; Gong, C. Polymeric Micelles Encapsulating Fisetin Improve the Therapeutic Effect in Colon Cancer ACS Appl. Mater. Interfaces 2015, 7, 534-542 10.1021/am5066893
33. Wen, Y.; Meng, W. S. Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid Tumors J. Pharm. Innov. 2014, 9, 158-173 10.1007/s12247-014-9183-4
34. Wang, J.; Sun, J.; Chen, Q.; Gao, Y.; Li, L.; Li, H.; Leng, D.; Wang, Y.; Sun, Y.; Jing, Y.; Wang, S.; He, Z. Star-shape Copolymer of Lysine-linked Di-tocopherol Polyethylene Glycol 2000 Succinate for Doxorubicin Delivery with Reversal of Multidrug Resistance Biomaterials 2012, 33, 6877-6888 10.1016/j.biomaterials.2012.06.019
35. Kataoka, K.; Matsumoto, T.; Yokoyama, M.; Okano, T.; Sakurai, Y.; Fukushima, S.; Okamoto, K.; Kwon, G. S. Doxorubicin-loaded Poly(ethylene glycol)-poly(beta- benzyl-L-aspartate) Copolymer Micelles: Their Pharmaceutical Characteristics and Biological Significance J. Controlled Release 2000, 64, 143-153 10.1016/S0168-3659(99)00133-9
36. Tang, J.; Fu, Q.; Wang, Y.; Racette, K.; Wang, D.; Liu, F. Vitamin E Reverses Multidrug Resistance in Vitro and in Vivo Cancer Lett. 2013, 336, 149-157 10.1016/j.canlet.2013.04.020
37. Lu, J.; Huang, Y.; Zhao, W.; Chen, Y.; Li, J.; Gao, X.; Venkataramanan, R.; Li, S. Design and Characterization of PEG-derivatized Vitamin E as a Nanomicellar Formulation for Delivery of Paclitaxel Mol. Pharmaceutics 2013, 10, 2880-2890 10.1021/mp300729y
38. Prajapati, R.; Sangamwar, A. T. Translocation Mechanism of P-glycoprotein and Conformational Changes Occurring at Drug-binding Site: Insights from Multi-targeted Molecular Dynamics Biochim. Biophys. Acta, Biomembr. 2014, 1838, 2882-2898 10.1016/j.bbamem.2014.07.018
39. Wempe, M. F.; Wright, C.; Little, J. L.; Lightner, J. W.; Large, S. E.; Caflisch, G. B.; Buchanan, C. M.; Rice, P. J.; Wacher, V. J.; Ruble, K. M.; Edgar, K. J. Inhibiting Efflux with Novel Non-ionic Surfactants: Rational Design Based on Vitamin E TPGS Int. J. Pharm. 2009, 370, 93-102 10.1016/j.ijpharm.2008.11.021
40. Lu, J.; Zhao, W.; Liu, H.; Marquez, R.; Huang, Y.; Zhang, Y.; Li, J.; Xie, W.; Venkataramanan, R.; Xu, L.; Li, S. An Improved D-α-tocopherol-based Nanocarrier for Targeted Delivery of Doxorubicin with Reversal of Multidrug Resistance J. Controlled Release 2014, 196, 272-286 10.1016/j.jconrel.2014.10.016
41. Sanpui, P.; Chattopadhyay, A.; Ghosh, S. S. Induction of Apoptosis in Cancer Cells at Low Silver Nanoparticle Concentrations using Chitosan Nanocarrier ACS Appl. Mater. Interfaces 2011, 3, 218-228 10.1021/am100840c
42. Garewal, H. S.; Ahmann, F. R.; Schifman, R. B.; Celniker, A. ATP Assay: Ability to Distinguish Cytostatic from Cytocidal Anticancer Drug Effects J. Natl. Cancer Inst. 1986, 77, 1039-1045
43. Yu, P.; Yu, H.; Guo, C.; Cui, Z.; Chen, X.; Yin, Q.; Zhang, P.; Yang, X.; Cui, H.; Li, Y. Reversal of Doxorubicin Resistance in Breast Cancer by Mitochondria-targeted pH-responsive Micelles Acta Biomater. 2015, 14, 115-124 10.1016/j.actbio.2014.12.001
44. Neuzil, J.; Dong, L. F.; Ramanathapuram, L.; Hahn, T.; Chladova, M.; Wang, X. F.; Zobalova, R.; Prochazka, L.; Gold, M.; Freeman, R.; Turanek, J.; Akporiaye, E. T.; Dyason, J. C.; Ralph, S. J. Vitamin E Analogues as a Novel Group of Mitocans: Anti-cancer Agents that Act by Targeting Mitochondria Mol. Aspects Med. 2007, 28, 607-645 10.1016/j.mam.2007.02.003
45. Wang, D. F.; Rong, W. T.; Lu, Y.; Hou, J.; Qi, S. S.; Xiao, Q.; Zhang, J.; You, J.; Yu, S. Q.; Xu, Q. TPGS2k/PLGA Nanoparticles For Overcoming Multidrug Resistance by Interfering Mitochondria of Human Alveolar Adenocarcinoma Cells ACS Appl. Mater. Interfaces 2015, 7, 3888-3901 10.1021/am508340m
46. Hugger, E. D.; Cole, C. J.; Raub, T. J.; Burton, P. S.; Borchardt, R. T. Automated Analysis of Polyethylene Glycol-induced Inhibition of P-glycoprotein Activity in Vitro J. Pharm. Sci. 2003, 92, 21-26 10.1002/jps.10265
47. Collnot, E. M.; Baldes, C.; Wempe, M. F.; Hyatt, J.; Navarro, L.; Edgar, K. J.; Schaefer, U. F.; Lehr, C. M. Influence of Vitamin E TPGS Poly(ethylene glycol) Chain Length on Apical Efflux Transporters in Caco-2 cell Monolayers J. Controlled Release 2006, 111, 35-40 10.1016/j.jconrel.2005.11.005
48. Ralph, S. J.; Rodríguez-Enríquez, S.; Neuzil, J.; Saavedra, E.; Moreno-Sánchez, R. The Causes of Cancer Revisited: 'Mitochondrial Malignancy' and ROS-induced Oncogenic Transformation-Why Mitochondria are Targets for Cancer Therapy Mol. Aspects Med. 2010, 31, 145-170 10.1016/j.mam.2010.02.008
49. Wang, A. T.; Liang, D. S.; Liu, Y. J.; Qi, X. R. Roles of Ligand and TPGS of Micelles in Regulating Internalization, Penetration and Accumulation against Sensitive or Resistant Tumor and Therapy for Multidrug Resistant Tumors Biomaterials 2015, 53, 160-172 10.1016/j.biomaterials.2015.02.077
50. Balducci, A.; Wen, Y.; Zhang, Y.; Helfer, B. M.; Hitchens, T. K.; Meng, W. S.; Wesa, A. K.; Janjic, J. M. A Novel Probe for the Non-invasive Detection of Tumor-associated Inflammation Oncoimmunology. 2013, 2, e23034 10.4161/onci.23034
51. Qin, C.; He, B.; Dai, W.; Lin, Z.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Wang, G.; Yin, L.; Zhang, Q. The Impact of a Chlorotoxin-modified Liposome System on Receptor MMP-2 and the Receptor-associated Protein ClC-3 Biomaterials 2014, 35, 5908-5920 10.1016/j.biomaterials.2014.03.077